10-K Filing

GLUCOSE HEALTH, INC. CIK: 1420108 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001214782-12-000044`
Period End Date	20111231
Filing Date	20120531
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	bisu-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 40 Cash Flow Statement 50 Stockholders Equity 27

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$33.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$82.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Inventory	`InventoryNet`	$87.76K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.73M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$27.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.73M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.44M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$27.08K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$87.79K	USD	Point-in-time
Intellectual property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$233.68K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$87.79K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$384.51K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$296.43K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	$41.50K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	-	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$243.77K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$19.67K	USD	Point-in-time
Short - term loans - related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$49.16K	USD	Point-in-time
Short - term loans - related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$49.23K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$8.20K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$4.75K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$4.86K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$682.36K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$419.70K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$419.70K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$682.36K	USD	Point-in-time
Common stock, $0.001 par value, 90,000,000 shares authorized 65,440,397 and 19,731,258 shares issued and outstanding as of December 31, 2011 and December 31, 2010, respectively	`CommonStockValue`	$65.44K	USD	Point-in-time
Common stock, $0.001 par value, 90,000,000 shares authorized 65,440,397 and 19,731,258 shares issued and outstanding as of December 31, 2011 and December 31, 2010, respectively	`CommonStockValue`	$19.73K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$1.60M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$2.86M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.14M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	-	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$169.57K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-68.02K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-69.22K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-594.57K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-301.12K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-310.14K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$87.79K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$233.68K	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	Annual
REVENUE	`SalesRevenueGoodsNet`	$2.41K	USD	Annual
Beginning inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	$82.20K	USD	Point-in-time
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$8.91K	USD	Annual
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$-87.76K	USD	Annual
Ending inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	$82.20K	USD	Point-in-time
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	Annual
Total Cost of Revenues	`CostOfGoodsSold`	$3.35K	USD	Annual
GROSS PROFIT (LOSS)	`GrossProfit`	$-947.00	USD	Annual
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	Annual
Professional fees and wages	`SalariesAndWages`	$490.66K	USD	Annual
Professional fees and wages	`SalariesAndWages`	$788.86K	USD	Annual
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$85.29K	USD	Annual
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	$83.51K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$14.67K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$39.73K	USD	Annual
[OperatingExpenses]	`OperatingExpenses`	$613.90K	USD	Annual
[OperatingExpenses]	`OperatingExpenses`	$888.81K	USD	Annual
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-614.85K	USD	Annual
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-888.81K	USD	Annual
Interest expense	`InterestExpense`	$10.37K	USD	Annual
Interest expense	`InterestExpense`	$17.89K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-10.37K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-17.89K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-632.74K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-899.19K	USD	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	36.26M	shares	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	18.25M	shares	Annual
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.03	USD	Annual
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.02	USD	Annual
Net loss	`NetIncomeLoss`	$-632.74K	USD	Annual
Net loss	`NetIncomeLoss`	$-899.19K	USD	Annual
Currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.20K	USD	Annual
Currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-26.76K	USD	Annual
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-724.29K	USD	3 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-176.09K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-900.38K	USD	Annual
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-659.50K	USD	Annual

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-632.74K	USD	Annual
Net loss	`NetIncomeLoss`	$-899.19K	USD	Annual
Amortization expense - license	`AmortizationOfIntangibleAssets`	$48.54K	USD	Annual
Amortization expense - license	`AmortizationOfIntangibleAssets`	-	USD	Annual
Impairment expense	`AssetImpairmentCharges`	$85.29K	USD	Annual
Impairment expense	`AssetImpairmentCharges`	$34.97K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$701.01K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$336.05K	USD	Annual
(Increase) decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
(Increase) decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.01K	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	$897.00	USD	Annual
(Increase) decrease in inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$102.43K	USD	Annual
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$89.58K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$523.10K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$875.88K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-109.64K	USD	Annual
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-23.30K	USD	Annual
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	$11.48K	USD	Annual
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$114.68K	USD	Annual
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.39K	USD	Annual
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	$6.66K	USD	Annual
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	$2.48K	USD	Annual
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	-	USD	Annual
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$8.20K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$20.77K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$121.34K	USD	Annual
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.58K	USD	Annual
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-11.67K	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$49.00	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$29.00	USD	Annual
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$4.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$4.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Conversion of Notes Payable to common stock	`DebtConversionOriginalDebtAmount1`	$246.61K	USD	Annual
Conversion of Notes Payable to common stock	`DebtConversionOriginalDebtAmount1`	$30.00K	USD	Annual
Conversion of accounts payable to common stock	`StockIssued1`	$152.68K	USD	Annual
Conversion of accounts payable to common stock	`StockIssued1`	-	USD	Annual
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$206.60K	USD	Annual
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	Annual
Conversion of accounts payable to equity (Note 9)	`DebtConversionOriginalDebtAmount2`	-	USD	Annual
Conversion of accounts payable to equity (Note 9)	`DebtConversionOriginalDebtAmount2`	$73.75K	USD	Annual

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Balance at beginning	`StockholdersEquity`	$-594.57K	USD	Point-in-time
Balance at beginning	`StockholdersEquity`	$-301.12K	USD	Point-in-time
Balance at beginning	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Balance at beginning, shares	`CommonStockSharesOutstanding`	19.73M	shares	Point-in-time
Balance at beginning, shares	`CommonStockSharesOutstanding`	65.44M	shares	Point-in-time
Common shares issues for services	`StockIssuedDuringPeriodValueShareBasedCompensation`	$298.55K	USD	Annual
Common shares issues for services	`StockIssuedDuringPeriodValueShareBasedCompensation`	$607.82K	USD	3 Qtrs
Common shares issues for services	`StockIssuedDuringPeriodValueShareBasedCompensation`	$10.00K	USD	1 Quarter
Common shares issued for settlement of accounts payable	`StockIssuedDuringPeriodValueOther`	$152.68K	USD	3 Qtrs
Common shares issued for settlement of accounts payable	`StockIssuedDuringPeriodValueOther`	$67.50K	USD	Annual
Common shares issued for settlement of accounts payable, shares	`StockIssuedDuringPeriodSharesOther`	-	shares	Annual
Common shares issued for settlement of notes payable	`CommonSharesIssuedForSettlementOfNotesPayable`	$9.86K	USD	1 Quarter
Common shares issued for settlement of notes payable	`CommonSharesIssuedForSettlementOfNotesPayable`	$236.75K	USD	3 Qtrs
Proceeds from issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$11.48K	USD	3 Qtrs
Common shares issued for Type 2 Acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$206.60K	USD	1 Quarter
Conversion of accounts payable to equity (Note 9)	`AdjustmentsToAdditionalPaidInCapitalOther`	$73.75K	USD	1 Quarter
Net loss for the year	`ComprehensiveIncomeNetOfTax`	$-724.29K	USD	3 Qtrs
Net loss for the year	`ComprehensiveIncomeNetOfTax`	$-176.09K	USD	1 Quarter
Net loss for the year	`ComprehensiveIncomeNetOfTax`	$-900.38K	USD	Annual
Net loss for the year	`ComprehensiveIncomeNetOfTax`	$-659.50K	USD	Annual
Balance at end	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Balance at end	`StockholdersEquity`	$-594.57K	USD	Point-in-time
Balance at end	`StockholdersEquity`	$-301.12K	USD	Point-in-time
Balance at end	`StockholdersEquity`	$-310.14K	USD	Point-in-time
Balance at end, shares	`CommonStockSharesOutstanding`	19.73M	shares	Point-in-time
Balance at end, shares	`CommonStockSharesOutstanding`	65.44M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.